Chiyu Banking Corporation Limited

Company Information

SZ
301290
CANOPUS MEDICAL

Company Profile

Industry

制造业

Company Introduction

公司主要从事以吻合器为代表的外科手术医疗器械的研发、生产和销售。公司长期深耕医疗器械领域，通过内生式发展和外延式扩张，不断拓展和延伸产品线，从初期代理销售国内外知名品牌的外科手术器械起步，逐渐发展为以吻合器及其组件为代表，覆盖多品类手术设备和医疗耗材的平台型集团化公司。公司从事国内外知名品牌的医疗器械代理业务超过20年，主要分为外科手术设备和低值耗材两类，代理销售的产品种类繁多，授权代理数量较为稳定，代理品牌包括明基三丰、迈瑞、碧迪、百合等，涉及外科手术室、麻醉科、急诊科、重症监护室等科室所需的医疗设备和耗材。公司通过收购威克医疗和孜航精密，实现了从吻合器产品研发设计、模具开发、零部件生产、产品组装至下游销售的全产业链布局。公司的核心子公司威克医疗是一家专注吻合器及微创外科产品研发创新和生产销售的省级高新技术企业，被评为国家级“专精特新小巨人企业”。截至2022年6月30日，威克医疗已取得31项医疗器械注册证及备案凭证，并作为生产企业第一起草单位，参与国家行业标准“内窥镜手术器械腔镜切割吻合器及组件”的起草。威克医疗的吻合器产品已覆盖国内数百家医疗机构，先后获得美国FDA、巴西ANVISA、韩国KFDA等多国认证，部分产品获得ISO 13485认证和CE认证，产品出口亚洲、欧洲、南美洲、非洲等多个国家和地区。公司的子公司孜航精密是集医疗器械组件研发、设计和加工为一体的高新技术企业，主要从事吻合器零部件和组件的研发、生产和销售，设计和生产的产品累计供应国内百余家吻合器厂商。孜航精密被评为2021年度常州市“专精特新”中小企业。公司围绕外科手术医疗器械逐渐丰富产品线，与明基三丰合资生产的医疗设备包括手术室吊塔吊桥、电动液压手术床、手术无影灯等。截至2022年6月30日，公司及子公司已形成丰富的专利布局，拥有专利155项，其中发明专利23项。公司取得43项医疗器械注册证及备案凭证，包括3项Ⅰ类、40项Ⅱ类医疗器材产品。随着我国医疗服务水平的提升、微创外科手术的普及，吻合器等外科医疗器械市场呈增长趋势，公司也将迎来良好的发展机遇。公司自主研发生产的主要产品包括腔镜吻合器、开放式吻合器、吻合器零部件、外科手术设备等

Main Business

主要从事以吻合器为代表的外科手术医疗器械的研发、生产和销售。

Legal Representative

万世平

Top Executives

董事长：	万世平
董事：	万世平,龚爱琴,魏建刚,万正元
独立董事：	朱旗,沈世娟,上官俊杰

Top 5 Shareholder

Shareholder name	Nature	Holding	Date
万世平	限售股+流通A股	25.02%	30/09/2024
江世华	流通A股	5.06%	30/09/2024
常州凯洲投资管理有限公司	限售股	4.49%	30/09/2024
王海龙	流通A股	4.30%	30/09/2024
苏州济峰股权投资合伙企业（有限合伙）	流通A股	4.13%	30/09/2024

Company Secretary

龚爱琴

Solicitors

北京市天元律师事务所

Auditors

立信会计师事务所（特殊普通合伙）

Tel No

0519-86632199

Fax No

0519-86638111

Website

www.dx-med.com

canopus@dx-med.com

Company Address

Register:	江苏省常州市武进区长扬路24-4号
Office:	江苏省常州市武进区长扬路24-4号

Listing Date

30/11/2022

Shares Capital

Shares Capital:	100,173,334
Total A Share:	100,173,334
Listed A Share:	68,179,150
Non-tradable A Share:	31,994,184
Other Share:	0
Total B Share:	0
Total H Share:	0

EPS(RMB)*

¥ 0.970

DPS(RMB)*

¥ 0.600

NBV Per Share(RMB)*

¥ 22.348

Market Capitalization(RMB)

1.735B

	Only Chinese content is avaliable
N / N : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only) N : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N / N : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only) N : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
*	Unadjusted Data

Disclaimer:

This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.

Information provided by: etnet
Terms and Conditions